Micro-dosing GLP-1 receptor agonists (drugs like semaglutide/Ozempic) could offer meaningful benefits while minimizing harmful side effects. There’s no doubt these drugs are incredibly effective for weight loss. But the high doses currently being used might be too much of a good thing. For example, high-dose GLP-1 receptor agonist use has been linked with a near doubling in the risk of suicidal behavior and a tripling in the risk of depression, as well as a two-fold increase in the risk of age-r

Stacking **AOD-9604** (a peptide targeting fat loss) and...